Skip to content

Evaluation of the effect of ultrasound therapy and nerve gliding techniques in patients with mild to moderate carpal tunnel syndrome

Evaluation of the effect of ultrasound therapy and nerve gliding techniques in patients with mild to moderate carpal tunnel syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190618043934N23
Enrollment
24
Registered
2023-11-18
Start date
2023-10-23
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: Intervention group 1 patients with carpal tunnel syndrome who are treated with ultrasound with a frequency of 1 megahertz, current intensity of 1 watt/cm2 3 times a

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having carpal tunnel syndrome based on clinical findings or electrodiagnostic criteria Not needing surgery and having mild to moderate disease symptoms based on muscle nerve strip and clinical examinations Not taking non-steroidal anti-inflammatory drugs or steroids before or during the intervention Balanced mental state and full satisfaction to participate in the research

Exclusion criteria

Exclusion criteria: Patients under 18 years of age Pregnant women Report of previous treatment of syndrome with ultrasound or laser or regular use of analgesic and anti-inflammatory drugs Use of local steroid injections inside the carpal tunnel during the last year or during the study Severe atrophy of the thenar region History of malignant tumors Having neuropathy of the peripheral system Having any disease that affects the results of the study Irregular attendance at treatment programs Unwillingness to participate in the study

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: At the beginning of the study and 4 weeks after the intervention in patients. Method of measurement: Using the visual pain scale questionnaire (VAS).;Severity of symptoms (paresthesia). Timepoint: At the beginning of the study and 4 weeks after the intervention in patients. Method of measurement: Using the Boston questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZabihullah Mohaghegh

Birjand University of Medical Sciences

oabstudent@gmail.com+98 56 3232 3232

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026